Cantor Fitzgerald, L. P. Cabaletta Bio, Inc. Transaction History
Cantor Fitzgerald, L. P.
- $2.48 Billion
- Q4 2024
A detailed history of Cantor Fitzgerald, L. P. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 100,000 shares of CABA stock, worth $220,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$220,000% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CABA
# of Institutions
115Shares Held
39.6MCall Options Held
297KPut Options Held
98.6K-
Black Rock Inc. New York, NY4.76MShares$10.5 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.07MShares$8.96 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$8 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$6.31 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$6.07 Million1.64% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $63.8M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...